NCT01467193

Brief Summary

This study aims at assessing the effect of standardized dietary fat load and short-term aerobic exercise on systemic lipolysis, flexibility and partitioning of ectopic fat stores (intramyocellular = IMCL, intrahepatocellular = IHCL, intramyocardial lipids = IMCaL) in relation to FFA in endurance trained athletes and hypopituitary patients compared to sedentary healthy control subjects. Exercise is a powerful stimulation for growth hormone (GH) secretion in health. A standardised exercise test can, therefore, be discriminative for the diagnosis of GH-deficiency in adults. This will be assessed. Hypothesis (ectopic fat stores)

  1. 1.Ectopic fats stores are flexible fuel stores and are influenced by diet and physical activity.FFA availability may play an important regulatory role.
  2. 2.There is a tissue specific partitioning of triglycerides and/or FFA among non-adipose organs after fat load and physical exercise
  3. 3.The flexibility of ectopic fat stores is related to insulin sensitivity
  4. 4.Lipolytic and anti-lipolytic hormones are critical for regulating FFA availability (at rest or during exercise) and therefore also for the regulation of ectopic fat stores.
  5. 5.GH is a lipolytica hormone. Lack of GH in adulthood is related to decreased FFA availability thereby influencing ectopic lipid stores Hypothesis diagnosis of GHD
  6. 6.A short intensive physical exercise shows a good discriminative power to diagnose GHD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 3, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 8, 2011

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
Last Updated

October 9, 2018

Status Verified

October 1, 2018

Enrollment Period

2.8 years

First QC Date

November 3, 2011

Last Update Submit

October 8, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Flexibility of IMCaL, IMCL and IHCL (fat load and exercise)

    Year 1 to 4

Secondary Outcomes (3)

  • Determination of visceral fat mass by MRI

    Year 1 to 4

  • Determination of peripheral and hepatic insulin sensitivity by two step hyperinsulinemic euglycemic clamp

    Year 1 to 3

  • maximal exercise capacity

    Year 1 to 3

Study Arms (3)

1

Endurance trained athletes: minimal \>50 mlO2/KG body weight

2

Sedentary healthy control subjects: age, BMI, Gender and waist matched (to the growth hormone deficient patients)

3

GHD patients without a GH substitution therapy in the last 6 months

Dietary Supplement: Fat dietOther: 2h standardized aerobic exercise

Interventions

Fat dietDIETARY_SUPPLEMENT

Instructions for a high fat diet will be given at the end of visit 2. This consists of the usual food intake with a supplementary fat intake of 0.75g fat/kg BW, administered as 3 additional snacks. These snacks will be distributed in pre-packed bags. A food diary will be kept. All arms will receive this diet during the 3 days preceding the clamp.

3

Aerobic (50-60% of Vo2 max) standardized exercise on a bicycle during 2 hours

3

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Athletes:Endurance trained athletes: minimal \>50 mlO2/KG body weight GH-deficient adult patients: NO GH-replacement therapy during the last 6 months Sedentary controls: age, BMI, Gender and waist matched (to the growth hormone deficient patients) healthy control subjects

You may qualify if:

  • Male and female patients \>18 years old
  • Capable to exercise for 120 minutes on a treadmill
  • Willingness to participate in the study and to give written consent.
  • Normal ECG during ergometry
  • Specific for Athletes: VO2max\> 50 ml/kg/min
  • Specific for GHD patients: no GH substitution in the last 6 months
  • Specific for sedentary controls: Matched the GHD patients for age, gender, BMI and waist

You may not qualify if:

  • Abnormal liver or renal function
  • Active neoplasia
  • Severe cardiovascular disease (unstable coronary artery disease, heart failure NYHA III-IV)
  • Haemophilia
  • Inability to exercise
  • Contraindications to exposure to a 3 T magnetic field
  • Abnormal ECG during ergometry
  • Women in childbearing age unless on a continuous contraceptive therapy or surgically sterilized
  • Depression, psychosis and other severe personality disorders
  • Pregnant women
  • Excessive alcohol consumption (\>60g/d) or drug abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Bern

Bern, 3010, Switzerland

Location

Related Publications (2)

  • Zueger T, Alleman S, Christ ER, Stettler C. Exercise-induced GH secretion in the assessment of GH deficiency in adult individuals. Eur J Endocrinol. 2011 Nov;165(5):723-8. doi: 10.1530/EJE-11-0539. Epub 2011 Aug 19.

  • Loher H, Jenni S, Bucher J, Krusi M, Kreis R, Boesch C, Christ E. Impaired repletion of intramyocellular lipids in patients with growth hormone deficiency after a bout of aerobic exercise. Growth Horm IGF Res. 2018 Oct-Dec;42-43:32-39. doi: 10.1016/j.ghir.2018.08.001. Epub 2018 Aug 17.

MeSH Terms

Conditions

Insulin ResistanceDwarfism, Pituitary

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesDwarfismBone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesBone Diseases, EndocrineHypopituitarismPituitary DiseasesHypothalamic DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEndocrine System Diseases

Study Officials

  • Emanuel Christ, Prof. Dr med. MD, PhD

    Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Bern

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 3, 2011

First Posted

November 8, 2011

Study Start

August 1, 2011

Primary Completion

May 1, 2014

Study Completion

May 1, 2014

Last Updated

October 9, 2018

Record last verified: 2018-10

Locations